PDA Letter Article

Know Your Numbers for Analytical Similarity

by Emanuela Lacana, PhD, U.S. FDA


Despite an increase in the approval of biosimilars in the United States, the development of biosimilar products continues to be challenging. Some questions about them have been partially resolved, such as the number of lots needed for the analytical similarity exercise, while others are still under discussion.